$BIIB Headlines The market puts a few feathers in its cap

New Post Public Reply Private Reply Replies (0) Message Board

Jan 25, 2014 at 1:00 PM

$BIIB Headlines

The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 3:54 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 4:22 p.m. Jan. 14, 2014 - Ben Eisen
Beam up on Suntory deal; Elliott report lifts Juniper 4:17 p.m. Jan. 13, 2014 - Saumya Vaishampayan
Biogen, Sangamo partner on hemoglobin therapies 9:38 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 4:24 p.m. Jan. 8, 2014 - Ben Eisen
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:28 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:32 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:18 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:55 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Ben Eisen
Biogen surges 13%, best on S&P 500 9:33 a.m. Nov. 22, 2013 - Laura Mandaro
The Four Horsemen send a message 12:46 p.m. Nov. 13, 2013 - The Trading Deck
Biogen shares hit new high as Tecfidera sales crush estimates 10:50 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Biogen Idec profit up 22% on Tecfidera sales boost 8:09 a.m. Oct. 28, 2013 - MarketWatch.com

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:08 p.m. Jan. 24, 2014 - TheStreet.com
Several IBD 50 Stocks Tumble Below 50-Day Lines 5:57 p.m. Jan. 24, 2014 - Investors Business Daily
Is There A Rally Ahead For Healthcare Stocks After Bristol Meyers Beat Earnings? 4:58 p.m. Jan. 24, 2014 - TheStreet.com
Will Bristol-Myers (BMY) Beat Q4 Earnings? - Analyst Blog 4:45 p.m. Jan. 23, 2014 - Zacks.com
Why Leverage Is Pointless 3:34 p.m. Jan. 23, 2014 - Seeking Alpha
Biotech Bull Market Key Trend No. 1: 5 Large Cap Biopharmas Plus 2 11:39 a.m. Jan. 23, 2014 - Seeking Alpha
The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron 8:00 a.m. Jan. 23, 2014 - TheStreet.com
Baxter's Profit Falls 34% on Expenses 7:37 a.m. Jan. 23, 2014 - WSJ.com
Cowen names its top biotech stocks with biggest upside to buy in 2014 6:45 p.m. Jan. 22, 2014 - Seeking Alpha
Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside 8:54 a.m. Jan. 22, 2014 - 247WallSt.com
Cramer's Lightning Round - Stay Long Kinder Morgan Partners (1/21/14) 6:36 a.m. Jan. 22, 2014 - Seeking Alpha
Biogen Idec Now #53 Largest Company, Surpassing Occidental Petroleum 4:41 p.m. Jan. 21, 2014 - TheStreet.com
Biogen Idec (BIIB) Showing Signs Of Being A Momo Momentum Stock 9:49 a.m. Jan. 21, 2014 - TheStreet.com
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry 7:19 a.m. Jan. 21, 2014 - Seeking Alpha
Can JNJ Keep the Earnings Streak Alive? - Analyst Blog 3:12 p.m. Jan. 20, 2014 - Zacks.com
Biogen Idec: 4 Different Insiders Have Sold Shares This Year 1:14 a.m. Jan. 20, 2014 - Seeking Alpha
GCVRZ: Betting On The Sales Of Lemtrada In A Moving MS Drug Market 2:05 p.m. Jan. 19, 2014 - Seeking Alpha
Gilead Is Not Done; There Is Potentially 50% More Upside This Year 5:32 p.m. Jan. 17, 2014 - Seeking Alpha
Biogen Idec Inc (BIIB): Today's Featured Drugs Winner 5:00 p.m. Jan. 17, 2014 - TheStreet.com
J.P. Morgan Confab Focus Reminds Us Upside Remains In Biotech 3:30 p.m. Jan. 17, 2014 - TheStreet.com

RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Critical Alerts For General Electric, SodaStream, Biogen Idec, Linn Energy, and Allscripts Released By InvestorsObserver 9:31 a.m. Jan. 24, 2014 - PR Newswire - PRF
RBCC Moves to the Front Lines of the 3D Bioprinting Revolution 5:00 a.m. Jan. 20, 2014 - BusinessWire - BZX
RBCC Prepares Big Push Into Booming 3D Bioprinting Market 5:00 a.m. Jan. 16, 2014 - BusinessWire - BZX
Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial Results on January 29, 2014 4:01 p.m. Jan. 15, 2014 - BusinessWire - BZX
RBCC Partner Therakine Presents Novel Drug Delivery Technology at Biotech Showcase 5:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Biogen Idec Announces Availability of FAMPYRA® in Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis 4:00 a.m. Jan. 15, 2014 - BusinessWire - BZX
Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific Officer Paul Stoffels with Lifetime Achievement Award at Annual East/West CEO Conference 9:49 a.m. Jan. 14, 2014 - BusinessWire - BZX
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer 9:10 a.m. Jan. 13, 2014 - PR Newswire - PRF
RBCC Partner n3D Commercializes New 3D Bioprinting Technology 5:53 a.m. Jan. 13, 2014 - BusinessWire - BZX
Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies 7:10 a.m. Jan. 9, 2014 - PR Newswire
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies 7:00 a.m. Jan. 9, 2014 - PR Newswire
Sunesis Pharmaceuticals Expands Hematology Franchise With Global Licenses to Two Kinase Inhibitor Programs 6:59 a.m. Jan. 9, 2014 - GlobeNewswire
Biogen Idec to Present at the 32nd Annual J.P. Morgan Healthcare Conference 5:29 p.m. Jan. 7, 2014 - BusinessWire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA 8:00 a.m. Jan. 7, 2014 - PR Newswire
Biogen Idec to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference 4:00 p.m. Jan. 2, 2014 - BusinessWire
Commercialization Agreements, Acquisition Updates, Conference Calls Schedules, Stock Price Updates and Clinical Study Data - Research Report on Biogen Idec, Covidien, Vertex, Endo, and Momenta Pharma 8:00 a.m. Dec. 31, 2013 - PR Newswire
Commercial Agreements, Stock Price Updates, Regulatory Approvals, Patent Litigation Settlements, and New Health Plan Strategies - Research Report on Biogen, Express Scripts, GSK, Actavis, and Aetna 8:00 a.m. Dec. 23, 2013 - PR Newswire
WCG Hires Adam Cohen, Digital Thought Leader, to Strengthen Technology Practice 8:00 a.m. Dec. 17, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...